secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)
CIK:        0001310488
Form:       8-K
Filed at:   2026-09-04T16:51:02+00:00
Accession:  0001091818-26-000140
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

BioForce issues 4.5M restricted shares for $2.48M in services
-------------------------------------------------------------

- On Aug 31, 2026, issued 4,516,909 restricted common shares for services valued at $2,484,300.
- Shares sold in private placement under Section 4(2); no commissions or fees paid.
- Purchasers represent investment intent; shares carry Rule 144 restrictive legend.
- CEO/CFO Richard Kaiser signed filing; company is an emerging growth company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1310488/000109181826000140/0001091818-26-000140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1310488/000109181826000140/bfnh-09042026_8k.htm
  HTML page:      https://secwatch.observer/filing/0001091818-26-000140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer